8:00 AM08:00

Healthcare Update over breakfast, with Jim Scopa

  • Tattersalls Club on Hyde Park (Level 2) (map)
  • Google Calendar ICS

Please join us for an update on the US life science market and its relevance to OneVentures’ investment strategy.

With Jim Scopa, member of the OneVentures Healthcare Advisory Panel, current Stanford
University fellow and former Managing Director for leading US venture capital firm MPM Capital.

The presentation will be held over breakfast, followed by a Q&A session, as well as a mixing segment where the OneVentures team will be in attendance.

Guest parking information →

About Jim Scopa

Jim Scopa is a fellow at Stanford University and previously was a Managing Director and member of the Investment Committee at MPM Capital, a US$2.6 billion US-based venture capital firm focused on early-stage life sciences technologies. Jim has led investments in biopharmaceuticals, medical devices and diagnostics. He currently serves on the boards of directors of Blade Therapeutics and Conatus Pharmaceuticals (CNAT:Nasdaq). He has previously served on the boards of Peplin (acquired by LEO Pharmaceuticals), iPierian (acquired by Bristol Myers Squibb), TriVascular (acquired by Endologix), True North Therapeutics (acquired by Bioverativ), Solasia KK (TYO) and Nevro (NYSE).

Prior to joining MPM, Jim spent 18 years in health care investment banking, advising emerging growth companies on public and private financings as well as mergers and acquisitions. Jim graduated from Harvard College and went on to complete a joint JD and MBA from Harvard Law School and Harvard Business School.



Name *
View Event →